Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 13, 2023British Journal of DermatologyOpen Access

Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAnna Rosala‐HallasUniversity of LiverpoolAJAshley P JonesUniversity of LiverpoolPBPaula BeattieNHS Greater Glasgow and Clyde

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosala‐Hallas et al. (2023) studied this question.

synapsesocial.com/papers/6aa9409c6dc8754dbe62eafbhttps://doi.org/10.1093/bjd/ljad281
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)2018 · 22 citations
  2. 2Retrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohnʼs Disease2014 · 45 citations
  3. 3Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*2020 · 633 citations
  4. 4Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy2000 · 282 citations
  5. 5Methotrexate Is a JAK/STAT Pathway Inhibitor2015 · 172 citations